Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-04-27
DOI
10.3389/fnagi.2018.00123
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
- (2017) Chin-Hsien Lin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study
- (2017) Manuel Delgado-Alvarado et al. MOVEMENT DISORDERS
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
- (2017) Günter U. Höglinger et al. MOVEMENT DISORDERS
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP
- (2017) Julio C. Rojas et al. NEUROLOGY
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
- (2017) Shieh-Yueh Yang et al. Scientific Reports
- Plasma Tau Levels in Cognitively Normal Middle-Aged and Older Adults
- (2017) Ming-Jang Chiu et al. Frontiers in Aging Neuroscience
- Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study
- (2016) H. Bea Kuiperij et al. JOURNAL OF ALZHEIMERS DISEASE
- Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
- (2016) Shieh-Yueh Yang et al. JOURNAL OF NANOBIOTECHNOLOGY
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- (2015) N K Magdalinou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative
- (2015) Brice Laurens et al. NEUROBIOLOGY OF DISEASE
- Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
- (2014) Nadia Magdalinou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications
- (2014) L. Chare et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Tau protein, beta-amyloid1–42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia
- (2014) Hana Přikrylová Vranová et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Alpha-synuclein and tau: teammates in neurodegeneration?
- (2014) Simon Moussaud et al. Molecular Neurodegeneration
- Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease
- (2013) Ming-Jang Chiu et al. HUMAN BRAIN MAPPING
- Criteria for the diagnosis of corticobasal degeneration
- (2013) M. J. Armstrong et al. NEUROLOGY
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies
- (2012) Connie Luk et al. JOURNAL OF NEUROCHEMISTRY
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- Biofunctionalized Magnetic Nanoparticles for Specifically Detecting Biomarkers of Alzheimer’s Disease in Vitro
- (2011) Che-Chuan Yang et al. ACS Chemical Neuroscience
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
- (2011) Y. Compta et al. BRAIN
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
- (2010) Walter J. Schulz-Schaeffer ACTA NEUROPATHOLOGICA
- Differential levels of -synuclein, -amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
- (2010) K. Kasuga et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome
- (2010) M.B. Aerts et al. MOVEMENT DISORDERS
- Differential pattern of brain-specific CSF proteins tau and amyloid-beta in Parkinsonian syndromes
- (2010) Sigurd D. Süssmuth et al. MOVEMENT DISORDERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Second consensus statement on the diagnosis of multiple system atrophy
- (2008) S. Gilman et al. NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started